SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neutropenia|Breast Cancer
Interventions: DRUG: SPI-2012|DRUG: Pegfilgrastim|DRUG: Docetaxel|DRUG: Cyclophosphamide
Sponsor: Spectrum Pharmaceuticals, Inc